Global Tecentriq Market Growth 2025-2031

December 2025 | 85 pages | ID: G756A8F85032EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Tecentriq market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Tecentriq is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tecentriq is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tecentriq is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tecentriq players cover Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Tecentriq Industry Forecast” looks at past sales and reviews total world Tecentriq sales in 2024, providing a comprehensive analysis by region and market sector of projected Tecentriq sales for 2025 through 2031. With Tecentriq sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tecentriq industry.

This Insight Report provides a comprehensive analysis of the global Tecentriq landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tecentriq portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tecentriq market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tecentriq and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tecentriq.

This report presents a comprehensive overview, market shares, and growth opportunities of Tecentriq market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 60mg/ml
  • Other
Segmentation by Application:
  • Urothelial Carcinoma
  • Non-Small Cell Lung Cancer (NSCLC)
  • Triple-Negative Breast Cancer (TNBC)
  • Small Cell Lung Cancer
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Roche
Key Questions Addressed in this Report

What is the 10-year outlook for the global Tecentriq market?

What factors are driving Tecentriq market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tecentriq market opportunities vary by end market size?

How does Tecentriq break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tecentriq Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Tecentriq by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Tecentriq by Country/Region, 2020, 2024 & 2031
2.2 Tecentriq Segment by Type
  2.2.1 60mg/ml
  2.2.2 Other
2.3 Tecentriq Sales by Type
  2.3.1 Global Tecentriq Sales Market Share by Type (2020-2025)
  2.3.2 Global Tecentriq Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Tecentriq Sale Price by Type (2020-2025)
2.4 Tecentriq Segment by Application
  2.4.1 Urothelial Carcinoma
  2.4.2 Non-Small Cell Lung Cancer (NSCLC)
  2.4.3 Triple-Negative Breast Cancer (TNBC)
  2.4.4 Small Cell Lung Cancer
2.5 Tecentriq Sales by Application
  2.5.1 Global Tecentriq Sale Market Share by Application (2020-2025)
  2.5.2 Global Tecentriq Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Tecentriq Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Tecentriq Breakdown Data by Company
  3.1.1 Global Tecentriq Annual Sales by Company (2020-2025)
  3.1.2 Global Tecentriq Sales Market Share by Company (2020-2025)
3.2 Global Tecentriq Annual Revenue by Company (2020-2025)
  3.2.1 Global Tecentriq Revenue by Company (2020-2025)
  3.2.2 Global Tecentriq Revenue Market Share by Company (2020-2025)
3.3 Global Tecentriq Sale Price by Company
3.4 Key Manufacturers Tecentriq Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tecentriq Product Location Distribution
  3.4.2 Players Tecentriq Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TECENTRIQ BY GEOGRAPHIC REGION

4.1 World Historic Tecentriq Market Size by Geographic Region (2020-2025)
  4.1.1 Global Tecentriq Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Tecentriq Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tecentriq Market Size by Country/Region (2020-2025)
  4.2.1 Global Tecentriq Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Tecentriq Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tecentriq Sales Growth
4.4 APAC Tecentriq Sales Growth
4.5 Europe Tecentriq Sales Growth
4.6 Middle East & Africa Tecentriq Sales Growth

5 AMERICAS

5.1 Americas Tecentriq Sales by Country
  5.1.1 Americas Tecentriq Sales by Country (2020-2025)
  5.1.2 Americas Tecentriq Revenue by Country (2020-2025)
5.2 Americas Tecentriq Sales by Type (2020-2025)
5.3 Americas Tecentriq Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tecentriq Sales by Region
  6.1.1 APAC Tecentriq Sales by Region (2020-2025)
  6.1.2 APAC Tecentriq Revenue by Region (2020-2025)
6.2 APAC Tecentriq Sales by Type (2020-2025)
6.3 APAC Tecentriq Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tecentriq by Country
  7.1.1 Europe Tecentriq Sales by Country (2020-2025)
  7.1.2 Europe Tecentriq Revenue by Country (2020-2025)
7.2 Europe Tecentriq Sales by Type (2020-2025)
7.3 Europe Tecentriq Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tecentriq by Country
  8.1.1 Middle East & Africa Tecentriq Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Tecentriq Revenue by Country (2020-2025)
8.2 Middle East & Africa Tecentriq Sales by Type (2020-2025)
8.3 Middle East & Africa Tecentriq Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tecentriq
10.3 Manufacturing Process Analysis of Tecentriq
10.4 Industry Chain Structure of Tecentriq

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tecentriq Distributors
11.3 Tecentriq Customer

12 WORLD FORECAST REVIEW FOR TECENTRIQ BY GEOGRAPHIC REGION

12.1 Global Tecentriq Market Size Forecast by Region
  12.1.1 Global Tecentriq Forecast by Region (2026-2031)
  12.1.2 Global Tecentriq Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tecentriq Forecast by Type (2026-2031)
12.7 Global Tecentriq Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Roche
  13.1.1 Roche Company Information
  13.1.2 Roche Tecentriq Product Portfolios and Specifications
  13.1.3 Roche Tecentriq Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Roche Main Business Overview
  13.1.5 Roche Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Tecentriq Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tecentriq Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 60mg/ml
Table 4. Major Players of Other
Table 5. Global Tecentriq Sales by Type (2020-2025) & (K Units)
Table 6. Global Tecentriq Sales Market Share by Type (2020-2025)
Table 7. Global Tecentriq Revenue by Type (2020-2025) & ($ million)
Table 8. Global Tecentriq Revenue Market Share by Type (2020-2025)
Table 9. Global Tecentriq Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Tecentriq Sale by Application (2020-2025) & (K Units)
Table 11. Global Tecentriq Sale Market Share by Application (2020-2025)
Table 12. Global Tecentriq Revenue by Application (2020-2025) & ($ million)
Table 13. Global Tecentriq Revenue Market Share by Application (2020-2025)
Table 14. Global Tecentriq Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Tecentriq Sales by Company (2020-2025) & (K Units)
Table 16. Global Tecentriq Sales Market Share by Company (2020-2025)
Table 17. Global Tecentriq Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Tecentriq Revenue Market Share by Company (2020-2025)
Table 19. Global Tecentriq Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Tecentriq Producing Area Distribution and Sales Area
Table 21. Players Tecentriq Products Offered
Table 22. Tecentriq Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Tecentriq Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Tecentriq Sales Market Share Geographic Region (2020-2025)
Table 27. Global Tecentriq Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Tecentriq Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Tecentriq Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Tecentriq Sales Market Share by Country/Region (2020-2025)
Table 31. Global Tecentriq Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Tecentriq Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Tecentriq Sales by Country (2020-2025) & (K Units)
Table 34. Americas Tecentriq Sales Market Share by Country (2020-2025)
Table 35. Americas Tecentriq Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Tecentriq Sales by Type (2020-2025) & (K Units)
Table 37. Americas Tecentriq Sales by Application (2020-2025) & (K Units)
Table 38. APAC Tecentriq Sales by Region (2020-2025) & (K Units)
Table 39. APAC Tecentriq Sales Market Share by Region (2020-2025)
Table 40. APAC Tecentriq Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Tecentriq Sales by Type (2020-2025) & (K Units)
Table 42. APAC Tecentriq Sales by Application (2020-2025) & (K Units)
Table 43. Europe Tecentriq Sales by Country (2020-2025) & (K Units)
Table 44. Europe Tecentriq Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Tecentriq Sales by Type (2020-2025) & (K Units)
Table 46. Europe Tecentriq Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Tecentriq Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Tecentriq Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Tecentriq Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Tecentriq Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Tecentriq
Table 52. Key Market Challenges & Risks of Tecentriq
Table 53. Key Industry Trends of Tecentriq
Table 54. Tecentriq Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Tecentriq Distributors List
Table 57. Tecentriq Customer List
Table 58. Global Tecentriq Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Tecentriq Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Tecentriq Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Tecentriq Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Tecentriq Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Tecentriq Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Tecentriq Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Tecentriq Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Tecentriq Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Tecentriq Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Tecentriq Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Tecentriq Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Tecentriq Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Tecentriq Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Roche Basic Information, Tecentriq Manufacturing Base, Sales Area and Its Competitors
Table 73. Roche Tecentriq Product Portfolios and Specifications
Table 74. Roche Tecentriq Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Roche Main Business
Table 76. Roche Latest Developments

LIST OF FIGURES

Figure 1. Picture of Tecentriq
Figure 2. Tecentriq Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tecentriq Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Tecentriq Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tecentriq Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tecentriq Sales Market Share by Country/Region (2024)
Figure 10. Tecentriq Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 60mg/ml
Figure 12. Product Picture of Other
Figure 13. Global Tecentriq Sales Market Share by Type in 2025
Figure 14. Global Tecentriq Revenue Market Share by Type (2020-2025)
Figure 15. Tecentriq Consumed in Urothelial Carcinoma
Figure 16. Global Tecentriq Market: Urothelial Carcinoma (2020-2025) & (K Units)
Figure 17. Tecentriq Consumed in Non-Small Cell Lung Cancer (NSCLC)
Figure 18. Global Tecentriq Market: Non-Small Cell Lung Cancer (NSCLC) (2020-2025) & (K Units)
Figure 19. Tecentriq Consumed in Triple-Negative Breast Cancer (TNBC)
Figure 20. Global Tecentriq Market: Triple-Negative Breast Cancer (TNBC) (2020-2025) & (K Units)
Figure 21. Tecentriq Consumed in Small Cell Lung Cancer
Figure 22. Global Tecentriq Market: Small Cell Lung Cancer (2020-2025) & (K Units)
Figure 23. Global Tecentriq Sale Market Share by Application (2024)
Figure 24. Global Tecentriq Revenue Market Share by Application in 2025
Figure 25. Tecentriq Sales by Company in 2025 (K Units)
Figure 26. Global Tecentriq Sales Market Share by Company in 2025
Figure 27. Tecentriq Revenue by Company in 2025 ($ millions)
Figure 28. Global Tecentriq Revenue Market Share by Company in 2025
Figure 29. Global Tecentriq Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Tecentriq Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Tecentriq Sales 2020-2025 (K Units)
Figure 32. Americas Tecentriq Revenue 2020-2025 ($ millions)
Figure 33. APAC Tecentriq Sales 2020-2025 (K Units)
Figure 34. APAC Tecentriq Revenue 2020-2025 ($ millions)
Figure 35. Europe Tecentriq Sales 2020-2025 (K Units)
Figure 36. Europe Tecentriq Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Tecentriq Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Tecentriq Revenue 2020-2025 ($ millions)
Figure 39. Americas Tecentriq Sales Market Share by Country in 2025
Figure 40. Americas Tecentriq Revenue Market Share by Country (2020-2025)
Figure 41. Americas Tecentriq Sales Market Share by Type (2020-2025)
Figure 42. Americas Tecentriq Sales Market Share by Application (2020-2025)
Figure 43. United States Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Tecentriq Sales Market Share by Region in 2025
Figure 48. APAC Tecentriq Revenue Market Share by Region (2020-2025)
Figure 49. APAC Tecentriq Sales Market Share by Type (2020-2025)
Figure 50. APAC Tecentriq Sales Market Share by Application (2020-2025)
Figure 51. China Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 55. India Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Tecentriq Sales Market Share by Country in 2025
Figure 59. Europe Tecentriq Revenue Market Share by Country (2020-2025)
Figure 60. Europe Tecentriq Sales Market Share by Type (2020-2025)
Figure 61. Europe Tecentriq Sales Market Share by Application (2020-2025)
Figure 62. Germany Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 63. France Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Tecentriq Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Tecentriq Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Tecentriq Sales Market Share by Application (2020-2025)
Figure 70. Egypt Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Tecentriq Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Tecentriq in 2025
Figure 76. Manufacturing Process Analysis of Tecentriq
Figure 77. Industry Chain Structure of Tecentriq
Figure 78. Channels of Distribution
Figure 79. Global Tecentriq Sales Market Forecast by Region (2026-2031)
Figure 80. Global Tecentriq Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Tecentriq Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Tecentriq Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Tecentriq Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Tecentriq Revenue Market Share Forecast by Application (2026-2031)


More Publications